Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overcoming chronic myeloid leukemia stem cell resistance to imatinib by also targeting JAK2.

× No keyword cloud information.

4 in total

1. Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells.

Authors: Nataliia V Guz; Sapan J Patel; Maxim E Dokukin; Bayard Clarkson; Igor Sokolov
Journal: Nanomedicine Date: 2016-07-16 Impact factor: 5.307

Review 2. Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.

Authors: Tariq I Mughal; Alessandro M Vannucchi; Simona Soverini; Alexandra Bazeos; Raoul Tibes; Giuseppe Saglio; Omar Abdel-Wahab; Animesh Pardanani; Rudiger Hehlmann; Tiziano Barbui; Richard Van Etten; Ayalew Tefferi; John M Goldman
Journal: Haematologica Date: 2014-05 Impact factor: 9.941

Review 3. Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches.

Authors: Anna Richter; Nina Schoenwaelder; Sina Sender; Christian Junghanss; Claudia Maletzki
Journal: Cancers (Basel) Date: 2021-05-20 Impact factor: 6.639

4. Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells.

Authors: Seiichi Okabe; Tetsuzo Tauchi; Seiichiro Katagiri; Yuko Tanaka; Kazuma Ohyashiki
Journal: J Hematol Oncol Date: 2014-04-28 Impact factor: 17.388

4 in total